Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial
Naoki Ito, Hitomi Saito, Shinobu Seki, Fumitaka Ueda and Takashi Asada
[Journal of Alzheimer’s Disease, 62(4)2018, 1767-1775, DOI 10.3233/JAD-170969]
https://content.iospress.com/articles/journal-of-alzheimers-disease/jad170969
On page 1769, left column, line 8, the following method of patient allocation is incorrectly given: “participants were assigned to the AS or placebo group using an alternating quasi-randomization allocation method.”
However, the following method was actually used: “non-alternating quasi-randomization allocation method”. With this method the controller, other researchers, and physicians do not know which group the next participants would be assigned to.
